Edwards Lifesciences Corporation (EW)
NYSE: EW · Real-Time Price · USD
74.81
+0.88 (1.19%)
Dec 20, 2024, 4:00 PM EST - Market closed
Edwards Lifesciences Analyst Ratings
Total Analysts
21
Consensus Rating
Buy
Price Target
$79.40
Upside
+6.14%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Hold → Strong Buy Upgrades $82 → $90 | Hold → Strong Buy | Upgrades | $82 → $90 | +20.30% | Dec 16, 2024 |
Citigroup | Citigroup | Strong Buy Maintains $81 → $83 | Strong Buy | Maintains | $81 → $83 | +10.95% | Dec 11, 2024 |
Goldman Sachs | Goldman Sachs | Strong Buy Maintains $81 → $90 | Strong Buy | Maintains | $81 → $90 | +20.30% | Dec 5, 2024 |
Truist Securities | Truist Securities | Hold Reiterates $70 → $78 | Hold | Reiterates | $70 → $78 | +4.26% | Dec 5, 2024 |
Stifel | Stifel | Hold Maintains $70 → $75 | Hold | Maintains | $70 → $75 | +0.25% | Dec 5, 2024 |
RBC Capital | RBC Capital | Buy Maintains $80 → $85 | Buy | Maintains | $80 → $85 | +13.62% | Dec 5, 2024 |
Canaccord Genuity | Canaccord Genuity | Hold Maintains $63 → $68 | Hold | Maintains | $63 → $68 | -9.10% | Dec 5, 2024 |
Barclays | Barclays | Buy Maintains $85 → $88 | Buy | Maintains | $85 → $88 | +17.63% | Dec 2, 2024 |
RBC Capital | RBC Capital | Buy Maintains $75 → $80 | Buy | Maintains | $75 → $80 | +6.94% | Nov 27, 2024 |
Canaccord Genuity | Canaccord Genuity | Hold Maintains $66 → $63 | Hold | Maintains | $66 → $63 | -15.79% | Oct 25, 2024 |
JP Morgan | JP Morgan | Hold Maintains $72 → $78 | Hold | Maintains | $72 → $78 | +4.26% | Oct 25, 2024 |
Piper Sandler | Piper Sandler | Hold Maintains $73 → $70 | Hold | Maintains | $73 → $70 | -6.43% | Oct 25, 2024 |
Truist Securities | Truist Securities | Hold Maintains $71 → $70 | Hold | Maintains | $71 → $70 | -6.43% | Oct 25, 2024 |
Baird | Baird | Hold Maintains $73 → $68 | Hold | Maintains | $73 → $68 | -9.10% | Oct 25, 2024 |
Morgan Stanley | Morgan Stanley | Hold Initiates $70 | Hold | Initiates | $70 | -6.43% | Oct 11, 2024 |
RBC Capital | RBC Capital | Buy Maintains $85 → $75 | Buy | Maintains | $85 → $75 | +0.25% | Oct 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.